Clinical Trial Update: Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating oral tranexamic acid and topical hydroquinone for the treatment of melasma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Tranexamic acid (oral) (tranexamic acid)
• hydroquinone (topical) (hydroquinone)

Snippet

Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Melasma | Phase 3 | Status: COMPLETED